Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Reversibility of symptomatic peripheral neuropathy with b... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose‐modification guideline
0
Authors
Paul Richardson
18 more
Paul Richardson
•
Thierry Facon
16 more
•
Jesús Miguel
Published
January 20, 2009
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
British Journal of Haematology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Endocrinology
Show all topics
DOI
10.1111/j.1365-2141.2008.07573.x
